2023 Opioid Use Disorder Treatment Outcomes Report

BayMark, a leading provider of medication-assisted treatment (MAT) for opioid use disorder (OUD), is thrilled to announce the release of its much-anticipated whitepaper, the “2023 Nationwide Opioid Use Disorder Treatment Outcomes Report”. This comprehensive study, conducted with one of the largest-ever data sets in the field, delves deep into the efficacy of medication-assisted treatment (MAT).

This detailed report, based on an exhaustive analysis of approximately 39,000 patients, offers a trove of knowledge and evidence-based clinical outcomes.